Bnp Paribas Asset Management Holding S.A. Abb Vie Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 338,055 shares of ABBV stock, worth $77.1 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
338,055
Previous 557,851
39.4%
Holding current value
$77.1 Million
Previous $117 Million
46.31%
% of portfolio
0.15%
Previous 0.31%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
4,364Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.2 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.51 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $403B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...